University of Helsinki
The University of Helsinki, established in 1640 and located in Finland, is a prominent non-profit educational institution that offers a broad range of disciplines and programs at both undergraduate and graduate levels. With eleven faculties and a student body of approximately 35,000, the University is dedicated to high-level scientific research and education, producing around 5,000 degrees annually, including about 470 doctorates. Its research activities underpin the teaching provided, contributing to societal development and benefiting business and industry. The University is involved in over half of the national Centres of Excellence in Research and is a member of the League of European Research Universities. Recognized for its high-quality education, the University maintains strong international connections, with around 80 cooperation agreements with institutions worldwide. Bilingual in Finnish and Swedish, the University also offers programs in English and operates at 20 locations across Finland.
Top Stages
7 past transactions
Solid IO
Pre Seed Round in 2025
Solid IO is a biotechnology company specializing in organ-on-chip technology for oncology. It replicates the tumor microenvironment to provide real-time, patient-specific insights, enabling clinicians to make precise treatment decisions and accelerating immuno-oncology drug development.
Moncyte
Seed Round in 2024
Moncyte Health is a personalized medicine company focused on advancing the treatment and prevention of cardiovascular disease, particularly high cholesterol. The company has developed patented technology that enables a cellular mechanism analysis test designed to identify patients who may not respond effectively to traditional statin treatments. This innovative approach allows healthcare providers to make informed, data-driven decisions tailored to individual patient needs, ultimately aiming to enhance treatment outcomes in the management of high cholesterol.
Moncyte
Grant in 2024
Moncyte Health is a personalized medicine company focused on advancing the treatment and prevention of cardiovascular disease, particularly high cholesterol. The company has developed patented technology that enables a cellular mechanism analysis test designed to identify patients who may not respond effectively to traditional statin treatments. This innovative approach allows healthcare providers to make informed, data-driven decisions tailored to individual patient needs, ultimately aiming to enhance treatment outcomes in the management of high cholesterol.
NADMED
Series A in 2024
NADMED develops NAD measurement technology designed to quantify all four NAD forms and glutathione. Its metabolite extraction system uses a nondestructive extraction method and colorimetric quantification to enable precise analysis across diverse biological samples. The technology supports research and clinical applications by providing measuring kits for laboratories and laboratory services, with use cases spanning cells, liver, brain, muscle, and blood from human or animal origin. NADMED aims to support researchers and clinicians in studying NAD metabolism and redox biology through accessible, reliable measurement tools.
Sustashift
Seed Round in 2024
Sustashift is a technology company that specializes in assisting businesses, both listed and non-listed, with their corporate sustainability reporting. They provide software solutions and advisory services to help companies comply with the Corporate Sustainability Reporting Directive (CSRD). Their platform offers pre-made templates and automated digital markup for sustainability reports, personalized audit templates, and automated XBRL tagging to streamline the compliance process.
Perfat Technologies
Seed Round in 2024
Perfat Technologies is a health-focused technology company that specializes in developing innovative fat-management applications using healthy vegetable oils. The company utilizes advanced oleogel and ultrasound technologies to create plant-based fats and alternative protein products, optimizing bioprocesses for enhanced research and development. This approach helps lower production costs and improve sustainability in food processing. By enhancing the techno-functionalities of oils such as rapeseed and sunflower, Perfat Technologies enables a broader application of these healthier alternatives in the food industry, promoting better choices for consumers.
Advans Microfinance Network
Debt Financing in 2021
Advans Microfinance Network is an international microfinance group that supports small businesses and underserved populations in Africa, the Middle East, and Asia. Founded in 2005 and headquartered in Luxembourg, Advans focuses on providing a range of financial services, including microloans, SME loans, insurance, and fund transfers. The organization aims to strengthen local businesses and improve living standards, contributing to private sector-led economic and social development. Advans operates through various microfinance institutions, such as Advans Tunisie, which offers tailored financial solutions to retailers, artisans, small industries, and farmers. By addressing the financial needs of these groups, Advans plays a crucial role in fostering entrepreneurship and job creation in the regions it serves.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.